Experts in Residence

The “Experts in Residence” scheme is managed by the Translational Research Office, the Business Partnerships Office and Oxford University Innovation. It aims to give Oxford's research community access to world-leading expertise and advice across multiple industry sectors. Scientists can arrange meetings with our experts to discuss their ideas and projects with no strings attached. We expect that this advice and support will help scientists develop the translational strategy for their projects/technologies.

View a brochure detailing the structure of the program, key stakeholders, testimonials, and a directory for researchers to learn more about the experts.

Our Experts

Book a meeting with one of our Experts in Residence

 Product Design in Biomedical Engineering 

Patrick Hall, Managing Director, Designing Science Ltd

Kerry Briggs, Head of Medical, Kinneir Dufort

James Holmes, Head of Electronics, Kinneir Dufort

Rouzet Agaiby, Associate Director, eg technology 

Giles Sanders, Diagnostics Development Lead, TTP

Stuart Lowe, Life Sciences consultant, TTP 

Imaging technologies 

Dr Jan Wolber, Product Leader - Digital, GE Healthcare Pharmaceutical Diagnostics  

 Drug Discovery and development 

Dr Rachel Grimley, Senior Vice President, Drug discovery, Cancer Research UK 

Professor Simon Hollingsworth, VP, Global Medicine Leader, AstraZeneca

Dr Rachel Hemsley, Business Development Director, Sygnature Discovery

Dr Colin T Dourish, Director and Co-Owner of P1vital and P1vital Products 

Dr Anthony Brown, VP Business Development & Scientific Liaison, Carrick Therapeutics

Dr Holger Hess-Stumpp, Former Director, Strategic Alliance Manager Oncology, Bayer, 

 Professor David Reynolds, CEO of LoQus 23 and AstronauTx  

Dr Tom Oakley, Somerville Development Partners

Dr Andrew Teasdale, Senior Principal Scientist Impurity Management and External Advocacy, AstraZeneca

Dr Yatish Lad, Vice President, Head of Early Development,  Oxford Biomedica (UK) Ltd.  

Dr Andy Pearce, Senior Director and Global Project Leader, AstraZeneca

Digital Health 

Dr Steve Gardner, Co-founder and CEO, PrecisionLife

Dr Veronique Bouchet, Chief Medical Officer, PrecisionLife;

Paul O'Donohoe, Scientific Lead, eCOA and Mobile Health, Medidata Solutions;

Bobby Kaura, Seed Investment, EMEA Outreach & International Development, Illumina Accelerator

Medical Technologies -  Regulatory and Market Access 

Dr Toni Day, Director of Quality and Regulatory Affairs at OrganOx

Richard Hall, QMS Consultancy

Ben Wensley-Stock, Managing Director MPS-UK and Wensley Stock Ltd 

Steven Haken, Director at Odelle Technology

Amy Peters, Director, Government Affairs and Policy, Johnson and Johnson MedTech

Diagnostics

Dr Adam Hill, Ceo of Oncimmune

Clinical Research

Dr Steve McConchie, Operations & Partnership Director for Lean Life Science 

Dr Matthew Reaney, Head of Patient Centered Endpoints, Science & Analytical Teams, IQVIA

Professor Jeremy Kirk, R&D Director Birmingham Women and Children’s Hospital and former CD NIHR Clinical Research Network for West Midlands

Innovation and commercial opportunities

 Paul Cox, General Manager, Apellis Pharmaceuticals

Nicholas Duggan, Founder at Zuas

  Dr Joanne Hackett, Head of Genomics and Precision Medicine, IQVIA

Dr Laura Ferguson, AstraZeneca

Dr Karen Wai, KW Health Advisory